Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.

Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs. Cancer Lett. 2010 Jun 01; 292(1):48-53.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.